ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
AB Corporate Bond ETF

AB Corporate Bond ETF (EYEG)

35.74
-0.08
(-0.21%)
마감 21 11월 6:00AM
35.74
0.00
( 0.00% )
시간외 단일가: 6:09PM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
35.74
매수가
14.30
매도가
56.82
거래량
-
0.00 일간 변동폭 0.00
34.52 52주 범위 37.24
market_cap
전일 종가
35.74
개장가
-
최근 거래 시간
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
567
발행 주식
7,689,000
배당수익률
-
주가수익률
-2.02
주당순이익(EPS)
-1.7
매출
-
순이익
-13.05M

AB Corporate Bond ETF 정보

The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers m... The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest. The Funds investment objective is to maximize total return through current income and longterm capital appreciation. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
AB Corporate Bond ETF is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker EYEG. The last closing price for AB Corporate Bond ETF was US$35.74. Over the last year, AB Corporate Bond ETF shares have traded in a share price range of US$ 34.52 to US$ 37.24.

AB Corporate Bond ETF currently has 7,689,000 shares in issue. The market capitalisation of AB Corporate Bond ETF is US$274.80 million. AB Corporate Bond ETF has a price to earnings ratio (PE ratio) of -2.02.

EYEG 최신 뉴스

EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City

WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced that the Company will attend and present at the 21st...

EyeGate Pharmaceuticals Announces Meeting Date with FDA

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today confirmed that it is scheduled to meet with the U.S. Food and...

EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial results for the three-month period ended...

EyeGate Pharma Announces Positive Results in Second PRK Study

Data confirms results from earlier study WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study evaluating...

EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care

WALTHAM, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules

WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies

WALTHAM, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.04230.11849502909235.697735.81535.62135.6946SP
4-0.33-0.91488771832536.0736.1135.610735.93359081SP
12-0.865-2.3630651550336.60537.2435.656736.72064369SP
260.391.1032531824635.3537.2434.9158636.40076215SP
520.541.5340909090935.237.2434.5251935.88308469SP
1560.541.5340909090935.237.2434.5251935.88308469SP
2600.541.5340909090935.237.2434.5251935.88308469SP

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
WORXSCWorx Corporation
US$ 1.85
(88.78%)
14.78M
AKTSAkoustis Technologies Inc
US$ 0.12985
(49.08%)
52.03M
PETWag Group Company
US$ 0.312
(48.50%)
16.27M
CRKNCrown Electrokinetics Corporation
US$ 1.13
(43.83%)
4.35M
ESGROEnstar Group Ltd
US$ 28.00
(40.92%)
24
WSBFWaterstone Financial Inc
US$ 9.00
(-40.98%)
4
TRSTriMas Corporation
US$ 15.62
(-40.79%)
3
BCAXBicara Therapeutics Inc
US$ 11.00
(-40.15%)
208
XNCRXencor Inc
US$ 15.11
(-36.30%)
2
PYXSPyxis Oncology Inc
US$ 2.44
(-36.13%)
201.93k
AKTSAkoustis Technologies Inc
US$ 0.12985
(49.08%)
52.03M
PETWag Group Company
US$ 0.312
(48.50%)
16.27M
WORXSCWorx Corporation
US$ 1.85
(88.78%)
14.78M
XTKGX3 Holdings Company Ltd
US$ 0.0797
(-11.44%)
10.59M
CRKNCrown Electrokinetics Corporation
US$ 1.13
(43.83%)
4.35M
WooptdooU WooptdooU 3 분 전
The x poster's PAST posts strongly supported the narrative of THE TAKE, the entire quarter of cash needs of the company of the NO REVENUE company to be paid out IN CASH, roughly $5.6 MILLION in cash....who does that?
The expiring stock options WERE WELL KNOWN and the x poster HELPED COVER THE
LWLG
PonkenPlonken PonkenPlonken 3 분 전
What is the point of this board? Parrot analyst notes and one upping each other on mega cap fundamentals?
x993231 x993231 3 분 전
Generation is singular.  Watch, we be taken over as a solution for generations.

X
LWLG
Magachic Magachic 4 분 전
style="caret-color: rgb(33, 33, 33); color: rgba(33, 33, 33, 1); font-family: -apple-system, HelveticaNeue; font-size: 25.92px"This one wants to run $$$$$$
SPRV
TrendTrade2016 TrendTrade2016 5 분 전
Reverse split coming here
TPTW
Nelson2 Nelson2 5 분 전
Insightful. From John CEO

“This time next year, we'll be having a conversation. What are you going to do with your cash? Are we going to do a buyback? Are you going to do a tuck-in with IoT? Are you going to -- so, that's what I would look for is the good problem of what we're going t
BB
ExtremelyBullishZig ExtremelyBullishZig 5 분 전
Too bad that no one followed up to see that the story was false. Where is Ern today?
AVXL
ExtremelyBullishZig ExtremelyBullishZig 6 분 전
It looks like it could maybe possibly work better than what is currently out there...it is what it is. Only a large properly planned trials would prove what you claim.
AVXL
rikkie rikkie 6 분 전
That's your opinion!
LWLG
budfoxfun budfoxfun 6 분 전
Company Blog - https://thesustainablegreenteam.com/sgtm-blog
SGTM
XMaster2023 XMaster2023 6 분 전
Investor82 you have no right to call Dr. Zivic a Liar or Pumper. Being a paid basher, that is trying to kill a company that is trying to cure cancer. I would say you have no right at all.
NWBO
TrendTrade2016 TrendTrade2016 7 분 전
PNG.V blow out earnings. Now this is what happens when you have a well run company with brilliant technology….my next company we are investing in is IMP.TO/ITMSF
IMP.TO has the same monthly chart and incredible technology
KRKNF
WooptdooU WooptdooU 7 분 전
Don't forget the x poster "acted" as a shareholder rep and presented the CORPORATE WELFARIST, GRIFTER a TROPHY... don't forget that role...it might be brought up again...
LWLG
ExtremelyBullishZig ExtremelyBullishZig 8 분 전
The lost of people who look at things correctly. Stop taking psychedelics and you will see what is going on at Anavex.
AVXL
PonkenPlonken PonkenPlonken 8 분 전
are you drinking the kool aid or pushing the agenda?
Data will matter in the end and they went above and beyond to cheat on the ph2...
The insider buying on this is a non-factor.
SAVA
GBR GBR 8 분 전
Another article on AWS Multi Agent Orchestrator.


Sure reads like aiWARE capabilities to me, but if not involved, then don't know what to say about this partnership with AWS.

https://www.marktechpost.com/2024/11/19/aws-releases-multi-agent-orchestrator-a-new-ai-f
VERI
ksquared ksquared 9 분 전
FJB... Biden admin quietly loosening immigration policies before Trump takes office — including letting migrants skip ICE check-ins in NYC
By Jennie Taer Published Nov. 21, 2024, 5:59 a.m. ET Former acting Customs and Border Protection Commissioner Mark Morgan slammed the Biden administ
MrSmithLWLG MrSmithLWLG 9 분 전
They don’t have the pieces to the puzzle solved, they are not ready for commercialization, they are 12 months from $0.05. Proto and the pumpers are FLAT WRONG and I feel bad for KCC, Lebby has been playing him LIKE A FIDDLE.
LWLG
WooptdooU WooptdooU 9 분 전
The x and kcc posters must feel used and abused? Pity, really.
LWLG
knrorrel knrorrel 9 분 전
$QBTS News is very good
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175418919
QBTS
uranium-pinto-beans uranium-pinto-beans 9 분 전
BJ
BJ's Wholesale reports Q3 adjusted EPS $1.18, consensus 93c
Reports Q3 revenue $5.1B, consensus $5.11B. Comparable club sales increased by 1.5% year-over-year. Comparable club sales, excluding gasoline sales, increased by 3.8% year-over-year, led by strong traffic. "Our third qua
Jake731 Jake731 10 분 전
Good morning y'all 😏




TPTW……!!!!!!!
TPTW
ExtremelyBullishZig ExtremelyBullishZig 10 분 전
That isn't the point. If a company gives 10 "artificial timelines" annually, andaybe delivers on one of them, they cannot be trusted toanage properly...it means they don't know how to manage projects...it is a problem.

If your wife constantly told you that she would be home from work
AVXL
knrorrel knrorrel 10 분 전
great news, so the QUANTUM computer from QBTS can't be that bad, in fact the opposite, that it is a real quality product $QBTS and with yesterday's news that the quantum computer from QBTS is now 25,000 times faster than the other servers - simply brilliant

you might think that $QBTS
QBTS
WooptdooU WooptdooU 11 분 전
This leads back to the UNadmiral ship jumper, head of the compensation committee, GRIFT and Run guy...wonder where that, hahaha hero, learned that move?
LWLG

최근 히스토리

Delayed Upgrade Clock